Reza Mehrazin MD

Dr. Reza Mehrazin is Associate Professor of Urology, Icahn School of Medicine at Mount Sinai. Dr. Mehrazin joined the surgical staff at Mount Sinai School of Medicine after completing a two-year Society of Urologic Oncology (SUO) accredited fellowship at a highly prestigious National Cancer Institute (NCI) designated cancer center, Fox Chase Cancer Center. Prior to his fellowship, he completed his general surgery internship and urology residency at University of Tennessee Health Science Center.

Dr. Mehrazin’s clinical expertise is in open, laparoscopic, and robotic surgical techniques for the treatment of various urologic cancers, which allows him to tailor a specific treatment plan based on individual patient need and preferences. He is one of the few urologists in the region who has extensive training and certified in performing minimally invasive organ preserving and reconstructive techniques to preserve function and quality of life for patients with kidney cancer and bladder cancer.

His research interests revolve around novel clinical and surgical treatment of kidney and bladder cancer. Over 220 of his abstracts have been presented at international, national, and regional scientific meetings. He has authored and co-authored over 85 scientific papers which are published or currently in press in major, high impact journals, such as The Journal of Urology, European Urology, and Urologic Oncology. His published work on the active surveillance of small renal masses (greater than 4 cm in size)is the largest single-center series reported to date.

In addition he has authored several text book chapters on kidney, prostate, and adrenal tumors. He has also served as an expert reviewer and medical correspondence writer for medical journals.